These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85. IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease. Winblad B; Grossberg G; Frölich L; Farlow M; Zechner S; Nagel J; Lane R Neurology; 2007 Jul; 69(4 Suppl 1):S14-22. PubMed ID: 17646619 [TBL] [Abstract][Full Text] [Related]
86. Effect of monthly high-dose vitamin D supplementation on falls and non-vertebral fractures: secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trial. Khaw KT; Stewart AW; Waayer D; Lawes CMM; Toop L; Camargo CA; Scragg R Lancet Diabetes Endocrinol; 2017 Jun; 5(6):438-447. PubMed ID: 28461159 [TBL] [Abstract][Full Text] [Related]
87. A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule. Winblad B; Cummings J; Andreasen N; Grossberg G; Onofrj M; Sadowsky C; Zechner S; Nagel J; Lane R Int J Geriatr Psychiatry; 2007 May; 22(5):456-67. PubMed ID: 17380489 [TBL] [Abstract][Full Text] [Related]
89. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Dinh A; Ropers J; Duran C; Davido B; Deconinck L; Matt M; Senard O; Lagrange A; Makhloufi S; Mellon G; de Lastours V; Bouchand F; Mathieu E; Kahn JE; Rouveix E; Grenet J; Dumoulin J; Chinet T; Pépin M; Delcey V; Diamantis S; Benhamou D; Vitrat V; Dombret MC; Renaud B; Perronne C; Claessens YE; Labarère J; Bedos JP; Aegerter P; Crémieux AC; Lancet; 2021 Mar; 397(10280):1195-1203. PubMed ID: 33773631 [TBL] [Abstract][Full Text] [Related]
90. Transcranial direct current stimulation (tDCS) in addition to walking training on walking, mobility, and reduction of falls in Parkinson's disease: study protocol for a randomized clinical trial. Nascimento LR; Nakamura-Palacios EM; Boening A; Cordeiro BNL; Cabral DL; Swarowsky A; Arêas GPT; Paiva WS; da Silva Arêas FZ Trials; 2021 Sep; 22(1):647. PubMed ID: 34548110 [TBL] [Abstract][Full Text] [Related]
91. Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial. Zakrzewska JM; Palmer J; Morisset V; Giblin GM; Obermann M; Ettlin DA; Cruccu G; Bendtsen L; Estacion M; Derjean D; Waxman SG; Layton G; Gunn K; Tate S; Lancet Neurol; 2017 Apr; 16(4):291-300. PubMed ID: 28216232 [TBL] [Abstract][Full Text] [Related]
92. Donepezil for gait and falls in mild cognitive impairment: a randomized controlled trial. Montero-Odasso M; Speechley M; Chertkow H; Sarquis-Adamson Y; Wells J; Borrie M; Vanderhaeghe L; Zou GY; Fraser S; Bherer L; Muir-Hunter SW Eur J Neurol; 2019 Apr; 26(4):651-659. PubMed ID: 30565793 [TBL] [Abstract][Full Text] [Related]
93. Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial. Trenkwalder C; Chaudhuri KR; Martinez-Martin P; Rascol O; Ehret R; Vališ M; Sátori M; Krygowska-Wajs A; Marti MJ; Reimer K; Oksche A; Lomax M; DeCesare J; Hopp M; Lancet Neurol; 2015 Dec; 14(12):1161-70. PubMed ID: 26494524 [TBL] [Abstract][Full Text] [Related]
94. Impact of depression on gait variability in Parkinson's disease. Dragašević-Mišković NT; Bobić V; Kostić M; Stanković I; Radovanović S; Dimitrijević K; Svetel M; Petrović I; Đurić-Jovičić M Clin Neurol Neurosurg; 2021 Jan; 200():106324. PubMed ID: 33129594 [TBL] [Abstract][Full Text] [Related]
95. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
96. Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial. Ford GA; Bhakta BB; Cozens A; Hartley S; Holloway I; Meads D; Pearn J; Ruddock S; Sackley CM; Saloniki EC; Santorelli G; Walker MF; Farrin AJ Lancet Neurol; 2019 Jun; 18(6):530-538. PubMed ID: 31122493 [TBL] [Abstract][Full Text] [Related]
97. Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial. Lotery A; Sivaprasad S; O'Connell A; Harris RA; Culliford L; Ellis L; Cree A; Madhusudhan S; Behar-Cohen F; Chakravarthy U; Peto T; Rogers CA; Reeves BC; Lancet; 2020 Jan; 395(10220):294-303. PubMed ID: 31982075 [TBL] [Abstract][Full Text] [Related]
98. Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial. Saad F; Thiery-Vuillemin A; Wiechno P; Alekseev B; Sala N; Jones R; Kocak I; Chiuri VE; Jassem J; Fléchon A; Redfern C; Kang J; Burgents J; Gresty C; Degboe A; Clarke NW Lancet Oncol; 2022 Oct; 23(10):1297-1307. PubMed ID: 36063830 [TBL] [Abstract][Full Text] [Related]
99. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial. Haal S; Guman MSS; Boerlage TCC; Acherman YIZ; de Brauw LM; Bruin S; de Castro SMM; van Hooft JE; van de Laar AWJM; Moes DE; Schouten M; Schouten R; van Soest EJ; van Veen RN; de Vries CEE; Fockens P; Dijkgraaf MGW; Gerdes VEA; Voermans RP Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):993-1001. PubMed ID: 34715031 [TBL] [Abstract][Full Text] [Related]
100. Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series. Bullock R; Cameron A Curr Med Res Opin; 2002; 18(5):258-64. PubMed ID: 12240787 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]